Mir-155 knockout protects against ischemia/reperfusion-induced brain injury and hemorrhagic transformation

Yalikun Suofu1, Xiaomin Wang1, Yanqing He1,2

  • 1Department of Neurological Surgery, Neuroapoptosis Laboratory, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Neuroreport
|December 27, 2019
PubMed

Insights

MicroRNA-155 (miR-155) upregulation after ischemic stroke worsens brain injury. Inactivating miR-155 reduces stroke damage and brain bleeding, suggesting miR-155 inhibition as a therapeutic strategy.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biomedical Research

Background:

  • MicroRNA-155 (miR-155) plays a complex role in regulating proteins involved in ischemic brain injury.
  • Existing research on miR-155's effect on cerebral ischemia/reperfusion (I/R) injury shows conflicting results.
  • The specific role of miR-155 in postischemic cerebral hemorrhagic transformation is not well understood.

Purpose of the Study:

  • To investigate the net effect of complete miR-155 inactivation on cerebral infarction and hemorrhagic transformation.
  • To evaluate the neuroprotective potential of miR-155 knockout in a mouse model of ischemic stroke.

Main Methods:

  • A middle cerebral artery occlusion (MCAO) model of cerebral ischemia/reperfusion (I/R) was used in wild type and miR-155 knockout mice.
  • Mice underwent 1 hour of MCAO followed by up to 71 hours of reperfusion.
  • Cerebral infarct size, hemorrhagic transformation incidence and extent, and neurological outcomes were assessed.

Main Results:

  • miR-155 was significantly upregulated in wild type mice after cerebral I/R.
  • miR-155 knockout mice exhibited smaller cerebral infarct sizes and improved neurological deficits compared to wild type.
  • Hemorrhagic burden, including incidence and volume, was significantly reduced in miR-155 knockout mice.

Conclusions:

  • Despite having opposing effects on various I/R-related processes, the net effect of miR-155 inactivation is neuroprotective.
  • The observed increase in miR-155 expression post-cerebral I/R is likely detrimental.
  • Inhibiting miR-155 presents a potential therapeutic target for mitigating ischemic brain injury and hemorrhagic transformation.

Related Concept Videos